Main Session
Sep
30
SS 33 - GI 2: Giving Radiation a Boost in Pancreatic Cancer and Responding to the Call for Esophageal Cancer
293 - Patient-Specific TP53-Mutant Circulating Tumor DNA as a Prognostic Biomarker for Detection of Minimal Residual Disease after Neoadjuvant Concurrent Chemoradiotherapy followed by Esophagectomy in Locally Advanced Esophageal Squamous Cell Carcinoma
Presenter(s)
Jason Chia-Hsien Cheng, MD, PhD, MS, FASTRO - National Taiwan University Hospital, Taipei, Taipei